{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:49:54Z","timestamp":1792594194039,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T00:00:00Z","timestamp":1519257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech, Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40744-018-0099-1","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T03:45:45Z","timestamp":1519271145000},"page":"159-170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Costs of Disease Relapses Among Individuals with Granulomatosis, with Polyangiitis, or Microscopic Polyangiitis in the United States"],"prefix":"10.1007","volume":"5","author":[{"given":"Amanda M.","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Michalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie H.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,22]]},"reference":[{"key":"99_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1\u201311.","journal-title":"Arthritis Rheum"},{"key":"99_CR2","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","volume":"53","author":"E Ntatsaki","year":"2014","unstructured":"Ntatsaki E, Carruthers D, Chakravarty K, et al. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford). 2014;53:2306\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"99_CR3","first-page":"279","volume":"2014","author":"RM Tarzi","year":"2014","unstructured":"Tarzi RM, Pusey CD. Current and future prospects in the management of granulomatosis with polyangiitis (Wegener\u2019s granulomatosis). Ther Clin Risk Manag. 2014;2014:279\u201393.","journal-title":"Ther Clin Risk Manag"},{"key":"99_CR4","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1001\/jama.298.6.655","volume":"298","author":"X Bosch","year":"2007","unstructured":"Bosch X, Guilabert A, Espinosa G, Mirapeix E. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis. JAMA. 2007;298:655\u201369.","journal-title":"JAMA"},{"key":"99_CR5","first-page":"80","volume":"30","author":"W Koldingsnes","year":"2003","unstructured":"Koldingsnes W, Nossent JC. Baseline features and initial treatment as predictors of remission and relapse in Wegener\u2019s granulomatosis. J Rheumatol. 2003;30:80\u20138.","journal-title":"J Rheumatol"},{"key":"99_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.7326\/0003-4819-143-9-200511010-00005","volume":"143","author":"SL Hogan","year":"2005","unstructured":"Hogan SL, Falk RJ, Chin H, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med. 2005;143:621\u201331.","journal-title":"Ann Intern Med"},{"key":"99_CR7","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1002\/art.23800","volume":"58","author":"C Pagnoux","year":"2008","unstructured":"Pagnoux C, Hogan SL, Chin H, et al. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts. Arthritis Rheum. 2008;58:2908\u201318.","journal-title":"Arthritis Rheum"},{"key":"99_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/art.27763","volume":"63","author":"JU Holle","year":"2011","unstructured":"Holle JU, Gross WL, Latza U, et al. Improved outcome in 445 patients with Wegener\u2019s granulomatosis in a German vasculitis center over four decades. Arthritis Rheum. 2011;63:257\u201366.","journal-title":"Arthritis Rheum"},{"key":"99_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","volume":"44","author":"JH Stone","year":"2001","unstructured":"Stone JH, Hoffman GS, Merkel PA, et al. A disease-specific activity index for Wegener\u2019s granulomatosis. Arthritis Rheum. 2001;44:912\u201320.","journal-title":"Arthritis Rheum"},{"key":"99_CR10","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3899\/jrheum.150479","volume":"42","author":"K Raimundo","year":"2015","unstructured":"Raimundo K, Farr AM, Kim G, Duna G. Clinical and economic burden of antineutrophil cytoplasmic antibody-associated vasculitis in the United States. J Rheumatol. 2015;42:2383\u201391.","journal-title":"J Rheumatol"},{"key":"99_CR11","unstructured":"Truven Health Analytics. MarketScan studies: abbreviated bibliography. [Internet. Accessed 21 June 2017]. \n                    http:\/\/sites.truvenhealth.com\/bibliography\/2014TruvenHealthMarketScanBibliography.pdf\n                    \n                  ."},{"key":"99_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363:221\u201332.","journal-title":"N Engl J Med"},{"key":"99_CR13","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613\u20139.","journal-title":"J Clin Epidemiol"},{"key":"99_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/ckj\/sfv020","volume":"8","author":"OO Rowaiye","year":"2015","unstructured":"Rowaiye OO, Kusztal M, Klinger M. The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis. Clin Kidney J. 2015;8:343\u201350.","journal-title":"Clin Kidney J."},{"key":"99_CR15","first-page":"248","volume":"32","author":"S Moiseev","year":"2017","unstructured":"Moiseev S, Novikov P, Jayne D, Mukhin N. End-stage renal disease in ANCA-associated vasculitis. Nephrol Dial Transplant. 2017;32:248\u201353.","journal-title":"Nephrol Dial Transplant"},{"key":"99_CR16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1440-1797.2005.00434.x","volume":"10","author":"MA Little","year":"2005","unstructured":"Little MA, Pusey CD. Glomerulonephritis due to antineutrophil cytoplasm antibody-associated vasculitis: an update on approached to management. Nephrology (Carlton). 2005;10:368\u201376.","journal-title":"Nephrology (Carlton)."},{"key":"99_CR17","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","volume":"41","author":"AD Booth","year":"2003","unstructured":"Booth AD, Almond MK, Burns A, et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003;41:776\u201384.","journal-title":"Am J Kidney Dis"},{"key":"99_CR18","first-page":"1237","volume":"27","author":"TM Mekhail","year":"2000","unstructured":"Mekhail TM, Hoffman GS. Long-term outcome of Wegener\u2019s granulomatosis in patients with renal disease requiring dialysis. J Rheumatol. 2000;27:1237\u201340.","journal-title":"J Rheumatol"},{"key":"99_CR19","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2215\/CJN.08290813","volume":"9","author":"T Lee","year":"2014","unstructured":"Lee T, Gasim A, Derebail VK, et al. Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure. Clin J Am Soc Nephrol. 2014;9:905\u201313.","journal-title":"Clin J Am Soc Nephrol"},{"key":"99_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12882-015-0082-9","volume":"16","author":"RL Manno","year":"2015","unstructured":"Manno RL, Seo P, Geetha D. Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study. BMC Nephrol. 2015;16:88.","journal-title":"BMC Nephrol."},{"key":"99_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1046\/j.1523-1755.2003.00769.x","volume":"63","author":"MC Slot","year":"2003","unstructured":"Slot MC, Tervaert JW, Franssen CF, Stegeman CA. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int. 2003;63:670\u20137.","journal-title":"Kidney Int"},{"issue":"3 Suppl 1","key":"99_CR22","first-page":"S1","volume":"67","author":"R Saran","year":"2016","unstructured":"Saran R, Li Y, Robinson B, et al. US Renal Data System 2015 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2016;67(3 Suppl 1):S1\u2013305.","journal-title":"Am J Kidney Dis"},{"key":"99_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/sdi.12464","volume":"29","author":"SD Weisbord","year":"2016","unstructured":"Weisbord SD. Patient-centered dialysis care: depression, pain, and quality of life. Semin Dial. 2016;29:158\u201364.","journal-title":"Semin Dial"},{"key":"99_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1681\/ASN.2013111233","volume":"26","author":"MJ Kemna","year":"2015","unstructured":"Kemna MJ, Damoiseaux J, et al. ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease. J Am Soc Nephrol. 2015;26:537\u201342.","journal-title":"J Am Soc Nephrol"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-018-0099-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40744-018-0099-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-018-0099-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T19:45:56Z","timestamp":1550778356000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40744-018-0099-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,22]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["99"],"URL":"https:\/\/doi.org\/10.1007\/s40744-018-0099-1","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,22]]},"assertion":[{"value":"14 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}